Literature DB >> 24561456

Runt-related transcription factor 3 is involved in the altered phenotype and function in ThPok-deficient invariant natural killer T cells.

Xia Liu, Shengxia Yin, Wenqiang Cao, Wei Fan, Lei Yu, Li Yin, Lie Wang, Jianli Wang.   

Abstract

The interplay between the CD4-lineage transcription factor ThPok and the CD8-lineage transcription factor, runt-related transcription factor 3 (Runx3), in T-cell development has been extensively documented. However, little is known about the roles of these transcription factors in invariant natural killer T (iNKT) cell development. CD1d-restricted iNKT cells are committed to the CD4(+)CD8(-) and CD4(-)CD8(-) sublineages, which respond to antigen stimulation with rapid and potent release of T helper (Th) 1 and Th2 cytokines. However, previous reports have demonstrated a new population of CD8(+) NKT cells in ThPok-deficient mice. In the current study, we sought to determine whether Runx3 was involved in the re-expression of CD8 and function of iNKT cells in the absence of ThPok. We used mice lacking Runx3, ThPok or both and verified that Runx3 was partially responsible for the appearance of CD8(+) iNKT cells in ThPok knockout mice. Additionally, Runx3 participated in the immune response mediated by iNKT cells in a model of α-galactosylceramide-induced acute hepatitis. These results indicate that Runx3 is crucial for the phenotypic and functional changes observed in ThPok-deficient iNKT cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24561456      PMCID: PMC4085493          DOI: 10.1038/cmi.2014.3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  59 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.

Authors:  Takeshi Egawa; Gerard Eberl; Ichiro Taniuchi; Kamel Benlagha; Frederic Geissmann; Lothar Hennighausen; Albert Bendelac; Dan R Littman
Journal:  Immunity       Date:  2005-06       Impact factor: 31.745

Review 3.  Tests of liver injury.

Authors:  Kenneth A Musana; Steven H Yale; Ahmad S Abdulkarim
Journal:  Clin Med Res       Date:  2004-05

Review 4.  The biology of NKT cells.

Authors:  Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

5.  Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples.

Authors:  Stuart P Berzins; Andrew D Cochrane; Daniel G Pellicci; Mark J Smyth; Dale I Godfrey
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

6.  The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.

Authors:  Xiao He; Xi He; Vibhuti P Dave; Yi Zhang; Xiang Hua; Emmanuelle Nicolas; Weihong Xu; Bruce A Roe; Dietmar J Kappes
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

7.  Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells.

Authors:  Ivana M Djuretic; Ditsa Levanon; Varda Negreanu; Yoram Groner; Anjana Rao; K Mark Ansel
Journal:  Nat Immunol       Date:  2006-12-31       Impact factor: 25.606

8.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

9.  Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.

Authors:  Baerbel Grueter; Michaela Petter; Takeshi Egawa; Kirsten Laule-Kilian; Christine J Aldrian; Andreas Wuerch; Yvonne Ludwig; Hidehiro Fukuyama; Hedda Wardemann; Ralph Waldschuetz; Tarik Möröy; Ichiro Taniuchi; Viktor Steimle; Dan R Littman; Marc Ehlers
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

10.  The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection.

Authors:  Guangping Sun; Xiaolong Liu; Peter Mercado; S Rhiannon Jenkinson; Magdalini Kypriotou; Lionel Feigenbaum; Philippe Galéra; Rémy Bosselut
Journal:  Nat Immunol       Date:  2005-03-06       Impact factor: 25.606

View more
  5 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

2.  NuRD complex recruitment to Thpok mediates CD4+ T cell lineage differentiation.

Authors:  Yayi Gao; Monica Zamisch; Melanie Vacchio; Laura Chopp; Thomas Ciucci; Elliott L Paine; Gaelyn C Lyons; Jia Nie; Qi Xiao; Ekaterina Zvezdova; Paul E Love; Charles R Vinson; Lisa M Jenkins; Rémy Bosselut
Journal:  Sci Immunol       Date:  2022-06-10

3.  The zinc-finger transcription factor MAZR regulates iNKT cell subset differentiation.

Authors:  Maria Jonah Orola; Caroline Tizian; Ci Zhu; Liisa Andersen; Alexandra Franziska Gülich; Marlis Alteneder; Tatjana Stojakovic; Ursula Wiedermann; Michael Trauner; Wilfried Ellmeier; Shinya Sakaguchi
Journal:  Cell Mol Life Sci       Date:  2019-05-07       Impact factor: 9.261

4.  The differentiation of ROR-γt expressing iNKT17 cells is orchestrated by Runx1.

Authors:  Puspa Thapa; Bryce Manso; Ji Young Chung; Sinibaldo Romera Arocha; Hai-Hui Xue; Derek B Sant' Angelo; Virginia Smith Shapiro
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

5.  Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3.

Authors:  Shengxia Yin; Jingjing Yu; Bian Hu; Chenyu Lu; Xia Liu; Xianzhi Gao; Wei Li; Lina Zhou; Jianli Wang; Di Wang; Linrong Lu; Lie Wang
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.